Search

everythinglearnresearchcommunity

for

Search:↓

PRP injections increased hair density in men with hair loss but didn't work for everyone and more research is needed.

Combining longxuejie and finasteride effectively reduces bleeding during TURP without side effects.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Cryotherapy with precise temperature control is a promising treatment for alopecia areata.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Using tretinoin cream on the skin can get rid of hair plugs caused by Trichostasis spinulosa.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Current treatments for recurrent ischemic priapism are not well-defined and need more research.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Microneedling works better when combined with other treatments.

Mesotherapy with natural extracts and vitamins can improve hair loss and promote regrowth in most women.

Injecting any solution helps acne scars, and ultrasound is useful for checking treatment results.

Intralesional corticosteroid injections effectively treat scalp vitiligo.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Applying minoxidil on the scalp after mesotherapy injections caused temporary swelling.

Retinoic acid and DMSO improve gene delivery to mouse skin for potential hair and skin disease treatment.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.

Both botulinum toxin A and multivitamin mesotherapy effectively treat hair loss, with botulinum toxin A being the better single-session option.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

TNF-alpha inhibitors can cause various immune-related skin issues.

Cetuximab can cause eyelash growth, which is rare but manageable.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Injecting stem cells from a patient's own fat can improve hair growth in women with hair loss.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.